Use of Cardioprotective Dexrazoxane Is Associated with Increased Myelotoxicity in Anthracycline-Treated Soft-Tissue Sarcoma Patients / Spalato Ceruso, M; Napolitano, A; Silletta, M; Mazzocca, A; Valeri, S; Improta, L; Santini, D; Tonini, G; Badalamenti, G; Vincenzi, B. - In: CHEMOTHERAPY. - ISSN 0009-3157. - 64:2(2019), pp. 105-109. [10.1159/000501195]
Use of Cardioprotective Dexrazoxane Is Associated with Increased Myelotoxicity in Anthracycline-Treated Soft-Tissue Sarcoma Patients
Santini D;
2019
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
